Total Payments
$414,259
2024 Payments
$98,893
Companies
13
Transactions
571
Medicare Patients
4,126
Medicare Billing
$285,806
Payment Breakdown by Category
Other$388,999 (93.9%)
Food & Beverage$9,509 (2.3%)
Consulting$9,008 (2.2%)
Travel$6,570 (1.6%)
Education$172.78 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $388,999 | 180 | 93.9% |
| Food and Beverage | $9,509 | 279 | 2.3% |
| Consulting Fee | $9,008 | 12 | 2.2% |
| Travel and Lodging | $6,570 | 89 | 1.6% |
| Education | $172.78 | 11 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $272,600 | 331 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $102,498 | 154 | $0 (2024) |
| Mylan Specialty L.P. | $27,178 | 54 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $10,131 | 19 | $0 (2023) |
| ViiV Healthcare Company | $1,600 | 1 | $0 (2019) |
| Genentech USA, Inc. | $61.79 | 2 | $0 (2020) |
| Resmed Corp | $42.67 | 1 | $0 (2018) |
| Grifols USA, LLC | $39.94 | 2 | $0 (2018) |
| Advanced Respiratory, Inc | $37.99 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $21.76 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98,893 | 134 | GlaxoSmithKline, LLC. ($60,387) |
| 2023 | $130,706 | 129 | GlaxoSmithKline, LLC. ($102,810) |
| 2022 | $54,045 | 74 | GlaxoSmithKline, LLC. ($34,284) |
| 2021 | $50,734 | 68 | GlaxoSmithKline, LLC. ($31,964) |
| 2020 | $28,324 | 37 | GlaxoSmithKline, LLC. ($23,174) |
| 2019 | $23,318 | 38 | GlaxoSmithKline, LLC. ($19,672) |
| 2018 | $8,541 | 46 | AstraZeneca Pharmaceuticals LP ($4,616) |
| 2017 | $19,699 | 45 | AstraZeneca Pharmaceuticals LP ($13,012) |
All Payment Transactions
571 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $34.84 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $103.40 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,553.38 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | Cash or cash equivalent | $93.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Travel and Lodging | Cash or cash equivalent | $56.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $336.68 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $104.84 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $18.72 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $67.32 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,155 | 1,334 | $452,964 | $75,033 |
| 2022 | 10 | 1,026 | 1,197 | $412,246 | $70,879 |
| 2021 | 12 | 1,028 | 1,238 | $469,875 | $72,729 |
| 2020 | 13 | 917 | 1,083 | $431,029 | $67,164 |
Total Patients
4,126
Total Services
4,852
Medicare Billing
$285,806
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 96 | 96 | $58,272 | $14,976 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 235 | $49,585 | $14,764 | 29.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 157 | 161 | $147,165 | $13,795 | 9.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 148 | $46,472 | $12,958 | 27.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 86 | 86 | $82,907 | $7,053 | 8.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 101 | 109 | $14,722 | $3,302 | 22.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 71 | 71 | $23,430 | $2,274 | 9.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $6,800 | $2,183 | 32.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 188 | 232 | $6,960 | $1,652 | 23.7% |
| 95807 | Sleep study including heart rate and breathing attended by technician | Facility | 2023 | 12 | 13 | $9,711 | $586.82 | 6.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 60 | 61 | $2,196 | $529.54 | 24.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 32 | 33 | $2,846 | $487.30 | 17.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 71 | 73 | $1,898 | $473.90 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 249 | $52,539 | $15,463 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 94 | 94 | $57,058 | $14,469 | 25.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 146 | 153 | $140,541 | $13,824 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 145 | $45,530 | $13,427 | 29.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 75 | 75 | $72,350 | $6,618 | 9.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 74 | 74 | $24,420 | $2,473 | 10.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 54 | 56 | $7,418 | $1,728 | 23.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 167 | 194 | $5,820 | $1,402 | 24.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 56 | 62 | $3,700 | $777.34 | 21.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 53 | 55 | $1,430 | $349.01 | 24.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 39 | 40 | $1,440 | $348.10 | 24.2% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 151 | 161 | $150,741 | $15,364 | 10.2% |
About Dr. Stephen Basheda, D.O
Dr. Stephen Basheda, D.O is a Sleep Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811004609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Basheda, D.O has received a total of $414,259 in payments from pharmaceutical and medical device companies, with $98,893 received in 2024. These payments were reported across 571 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($388,999).
As a Medicare-enrolled provider, Basheda has provided services to 4,126 Medicare beneficiaries, totaling 4,852 services with total Medicare billing of $285,806. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Pulmonary Disease
- Location Pittsburgh, PA
- Active Since 08/25/2006
- Last Updated 03/09/2021
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1811004609
Products in Payments
- AREXVY (Drug) $92,944
- TRELEGY ELLIPTA (Drug) $89,271
- BREZTRI (Drug) $63,234
- AIRSUPRA (Drug) $18,799
- Yupelri (Drug) $13,649
- YUPELRI (Drug) $13,483
- BEVESPI AEROSPHERE (Drug) $12,711
- ANORO (Drug) $7,489
- SYMBICORT (Drug) $4,853
- ANORO ELLIPTA (Drug) $2,405
- BREZTRI AEROSPHERE (Drug) $2,382
- NUCALA (Biological) $342.84
- TEZSPIRE (Biological) $252.85
- FASENRA (Biological) $140.59
- BREO (Drug) $101.19
- FASENRA (Drug) $95.44
- Xolair (Biological) $61.79
- Astral (Device) $42.67
- The Vest System Model 105 Home Care (Device) $37.99
- Perforomist (Drug) $25.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sleep Medicine Doctors in Pittsburgh
Sanjay Patel
Sleep Medicine — Payments: $16,233
Sleep Medicine $16,233
Dr. Thomas Kaffenberger, M.d, M.D
Sleep Medicine — Payments: $12,330
Sleep Medicine $12,330
Daniel Buysse
Sleep Medicine — Payments: $3,305
Sleep Medicine $3,305
Sushruta Cerejo, M.d, M.D
Sleep Medicine — Payments: $256.18
Sleep Medicine $256.18
Dr. Aaron Palmquist, Md, MD
Sleep Medicine — Payments: $229.39
Sleep Medicine $229.39
Sullafa Kadura, M.d, M.D
Sleep Medicine — Payments: $150.00
Sleep Medicine $150.00